Envision Pharma Group is a scientific communications and technology company that specializes in serving the life sciences sector, including pharmaceutical, biotechnology, and medical device industries. The company collaborates with clients, authors, and the medical publishing community to create and implement evidence-based communication programs in a transparent and compliant manner. Envision provides a comprehensive suite of services that includes artificial intelligence and natural language processing, integrated strategic consulting, scientific communications, health economics and outcomes research, market access, and data analytics. Its software solutions facilitate the development of global medical strategies and support cross-functional teams in managing scientific communications. This enables clients to effectively connect with their audiences and ensures compliance with regulatory standards throughout the product life cycle.
Chief of Staff, CEO and member of the Executive Leadership Team
7 past transactions
OKRA Technologies
Acquisition in 2023
OKRA Technologies is an artificial intelligence data analytics company focused on enhancing the healthcare sector through its innovative platform. This platform enables healthcare professionals to integrate multiple complex data sets, generating real-time evidence-based insights that aim to improve patient outcomes and inform critical decision-making. Users can interact with the data through a user-friendly search interface, posing natural language questions to receive actionable insights swiftly. OKRA's advanced algorithms also facilitate the prediction of future outcomes, allowing healthcare providers to make informed and efficient choices. The company has applied its technology in various contexts, including clinical trials and social services, to optimize treatment strategies and resource allocation.
doDOC
Acquisition in 2021
doDOC is a cloud-based document editing platform that enhances collaboration by allowing multiple users to work on the same document simultaneously. Founded in 2015 by MIT alumni and based in Boston, the company focuses on streamlining the writing and management processes to improve productivity. Its software features well-governed workflows and granular permissions, which can be adjusted down to the paragraph level, ensuring strict control over document access and modifications. Additionally, doDOC provides a comprehensive audit trail for all documents, making it suitable for organizations of all sizes, from startups to large enterprises. The platform aims to simplify the writing and review process, enabling teams to plan, draft, edit, and approve documents more than 70% faster without the complications of traditional systems.
Two Labs
Acquisition in 2020
Two Labs is a prominent pharmaceutical services company specializing in consultancy for the pharmaceutical and biotechnology sectors. It offers a comprehensive range of services, including market access, market intelligence, and commercialization support. With experience in leading over 200 new product launches and managing more than 290 in-market projects, Two Labs assists pharmaceutical manufacturers in navigating the complexities of the product lifecycle. The company's expertise encompasses strategic consulting, lifecycle management, and acquisition transition, allowing clients to effectively address challenges from strategy development to implementation.
90 Ten
Acquisition in 2020
90TEN is an independent healthcare communications consultancy.
Touch Creative Design
Acquisition in 2017
Touch Creative Design is a Pharma/Healthcare focused agency with multi-industry experience – predominantly healthcare focused they also work across other industries. This experience keeps their ideas fresh, allowing them to evaluate and experiment with the latest technologies and learn what works with respect to customer engagement. Specialties include: Creative strategy development; Digital & technology-based experiences; Exhibitions and Event services; Branding and traditional creative media.
Alligent Biopharm Consulting
Acquisition in 2015
Alligent Group is a medical affairs consulting agency that specializes in providing integrated and aligned medical communications solutions for the biopharmaceutical industry. Established in 2009 and based in Stirling, New Jersey, the company offers a comprehensive range of services, including medical strategy development, implementation support, impact analytics, and stakeholder engagement. Its expertise encompasses clinical trial design, data exploration, publication strategy, and thought leader planning, along with content development and training services. Alligent is dedicated to delivering timely and budget-conscious data to its clients, ensuring effective communication and engagement throughout the medical affairs process. The company operates as a subsidiary of Envision Pharma, Inc.
ProScribe
Acquisition in 2014
ProScribe is a company that was acquired by Envision Pharma Group in 2014.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.